BiosimilarDrug
Tbo-filgrastim clinical trials
A product of Filgrastim; its studies count on that page too.
How studies write it
Studies that test it under each name
Name
Development codes
- XM02
- 1
Studies by the year they started
3 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2017 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 1
Teva Branded Pharmaceutical Products R&D, Inc. (2) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)
Studies
Open first, then newest update. How each study uses Tbo-filgrastim is read from its arms, and is right about nine times in ten.
Testing it · 3
- Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin LymphomaCompletedPhase 2Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityNCT03317899Written as Tbo-filgrastim
- Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy ParticipantsTerminatedPhase 3Teva Branded Pharmaceutical Products R&D, Inc.NCT03029000Written as Tbo-filgrastim
- A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow InvolvementCompletedPhase 2Teva Branded Pharmaceutical Products R&D, Inc.NCT02190721Written as tbo-filgrastim